# BlossomHill Therapeutics, Inc. (BLSM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BLSM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -21.01M | $ -20.95M | $ 23.02M | $ -152.12M |
| 2025 | $ 0 | $ -10.73M | $ -11.65M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.15 |
| Liabilities / Eq | -1.94 |
| Current Ratio | 7.40 |

## Other views

- [Metrics](https://sponda.capital/en/BLSM.md)
- [Charts](https://sponda.capital/en/BLSM/charts.md)
- [Compare](https://sponda.capital/en/BLSM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.